SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) May 12, 1998
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On May 12, 1998 Biocontrol Technology, Inc.
(NASDAQ:BICO) announced today that all recently requested
clarification and information regarding the Company's Technical
File has now been supplied to its Notified Body, TUV Rheinland
Product Safety GmbH, Germany. The Technical File is part of
Biocontrol's process to obtain the CE Mark for its Diasensor 1000
noninvasive glucose sensor, which will allow the Diasensor to be
marketed in the European Community.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: May 12, 1998
BICO
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
For More Information, Call:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.279.9455 phone
1.412.279.9690 fax 1.412.279.9447 fax
BIOCONTROL SUPPLIES CLARIFICATION TO CE MARK FILE
Pittsburgh, PA - May 12, 1998 - Biocontrol Technology, Inc.
(Nasdaq:BICO) announced today that all recently requested
clarification and information regarding the Company's Technical
File has now been supplied to its Notified Body, TUV Rheinland
Product Safety GmbH, Germany. The Technical File is part of
Biocontrol's process to obtain the CE Mark for its Diasensor 1000
noninvasive glucose sensor, which will allow the Diasensor to be
marketed in the European Community.
Biocontrol President, David L. Purdy, reported that George
Cranstone, Managing Director of Euro Surgical Ltd., the Company's
recently appointed United Kingdom distributor, has been in
discussions with physicians and potential UK Diasensor customers
and informs Biocontrol that the response has been very positive.
Purdy also said that product "is on the shelf" and is ready to
ship to England as soon as approval to apply the CE Mark is
received.
Biocontrol Technology, Inc. (www.bico.com) has its corporate
offices in Pittsburgh, PA and is involved in the development and
manufacture of biomedical devices and environmental products.
